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Abstract 
Background 
The microbiota in our gut is an important component of normal physiology that has 
co-evolved with us from the earliest multicellular organisms. It is, therefore, not 
surprising that there is an intimate crosstalk between the microbial world in the gut 
and the host. Genome regulation through microbiota-host interactions not only affect 
the host’s immunity, but also metabolic health and resilience against cancer. 
Chromatin dynamics of the host epithelium involving histone modifications and other 
facets of the epigenetic machinery play an important role in this process.  
Scope of Review 
In this review we will discuss recent findings relevant to how chromatin dynamics 
shape the crosstalk between the microbiota and its host, with special focus on the 
role of histone modifications. 
Major Conclusions 
Host-microbiome interactions are important evolutionary drivers and are, thus, 
expected to be hardwired into and mould the epigenetic machinery in multicellular 
organisms. Microbial derived short chain fatty acids (SCFA) emerge as a dominant 
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determinant in microbiome-host interaction and the inhibition of histone deacetylases 
(HDACs) by SCFA is a key mechanism in this process. The discovery of alternative 
histone acylations, such as crotonylation, in addition to the canonical histone 
acetylation reveals a new layer of complexity in this crosstalk.  
 
The epigenome is shaped by the environment 
Each cell in the body of a multicellular eukaryotic organism usually has essentially 
the same genome in its nucleus, packaged into a highly complex superstructure 
known as chromatin. The basic building block of chromatin is the nucleosome, 
composed of eight core histones (H2A, H2B, H3, H4) around which DNA winds in 
almost two turns. An additional linker histone H1 ‘seals off’ this structure. Histone 
tails, normally unstructured but highly conserved peptide components of the 
histones, protrude from the core nucleosome body and are subject to a plethora of 
posttranslational modifications (PTMs). These various histone PTMs are critical 
components of gene and genome regulatory mechanisms and are thought to 
constitute something of a ‘regulatory language’ (the ‘histone code’), in part by 
creating binding sites for effector proteins, often called ‘readers’ (reviewed in: [1–3]). 
Histone acetylation is a paradigm histone PTM. This modification occurs on the 
epsilon amino groups of lysine residues on N-terminal tails of predominantly histones 
H3 and H4 and is associated with permissive, transcriptionally active chromatin. This 
modification is mediated by histone acetyltransferases (HATs, ‘writers’) and reversed 
by histone deacetylases (HDACs, ‘erasers’). 
Histone lysine methylations are PTMs that have also been well studied, but here the 
functional context is more complex compared to acetylation. For example, 
trimethylation of histone H3 at lysine 4 (H3K4me3) is strongly linked to active genes, 
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whereas trimethylation of histone H3 at lysines 9 (H3K9me3) or 27 (H3K27me3) are 
part of various gene repressive pathways [4]. 
The structure of nucleosomes are altered by a plethora of additional proteins of 
which ATP-dependent nucleosome remodelling factors are an important group 
(reviewed in [5,6]). These factors can catalyse the eviction or restructuring of 
nucleosomes, for example by histone dimer eviction or exchange of histone variants. 
These factors also affect the posttranslational modifications of histones, possibly by 
facilitating these enzymatic steps in a nucleosomal context.  
In addition to histones, DNA itself is modified, most commonly methylation of carbon-
5 position of cytosines at CpG dinucleotide sequences. Histone and DNA 
modifications are important components of epigenetic mechanisms, which not only 
allow cells to differentiate into many cell types from one genome blueprint, but also 
form a part of a cellular ‘memory’ [7]. This ‘memory’ is not only essential for a cell to 
‘remember’ its identity, but it also constitutes a mechanism by which a cell can 
integrate external cues, such as environmental influences. Other components of the 
epigenetic machinery are transcription factor networks and noncoding RNAs, 
including long noncoding RNAs and micro RNAs. Exactly what constitutes an 
epigenetic mechanism or what should be called ‘epigenetic’ has been subject of 
some debate, but we feel a practical, non-dogmatic approach is useful and we 
consider everything that moulds the functional output of the genome without 
changing the underlying DNA sequence to be ‘epigenetic’, remembering that ‘epi’ 
stems from Greek for ‘on top of’.  
Our microbiota are very dominant environmental factors that our bodies have to deal 
with, affecting health and disease. In this review we will discuss recent work 
investigating how the gut microbiota shapes the epigenome. This is a dynamic and 
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complex field and there have been a number of recent reviews covering various 
aspects [8–14]. We focus here on how this crosstalk shapes the host’s genome 
function through histone modifications and we discuss very recent papers. As this 
topic is complex and brings together several fields, we have a ‘glossary’ box to 
summarise or explain several critical terms (Table 1). 
 
The microbial world in us 
Our world is permeated, if not dominated, by microbes and we find microbes thriving 
in the most hostile environments on earth. Thus, it is not surprising to find that our 
bodies are also home to a staggering number and diversity of microbes, including 
bacteria, archaea, protists, yeasts and viruses. Technological developments, 
especially next generation sequencing based methods of metagenomics have 
revolutionised our understanding of the microbial world, including our microbiota. We 
have learned that complex ecosystems of microbes cover many mucosal surfaces of 
our body, such as the skin, gut, vagina, lungs, uterus and bladder [15–18].  
The microbiota and host have coevolved from the earliest multicellular organisms 
onwards and it has been argued that pressure on the host to control the microbiota 
has been an important evolutionary driver [19]. Thus, the host microbiome has been 
termed ‘an ecosystem on a leash’ [19]. As Foster et al., wrote: “Host control over the 
microbes (as opposed to microbial control of the host) can be predicted, because 
there is only one host in the interaction, in contrast to the myriad microbes. Thus, 
unlike individual microbes, a host can easily influence the entire microbiome, and 
benefit from doing so” [19]. Therefore, while we will present evidence in this review 
that the microbiota manipulates the epigenetic machinery for interaction with the 
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host, we can expect that this interaction also shaped the epigenetic machinery 
during evolution.  
In many mammals, including human, the greatest number of microbes are found in 
the colon (Figure 1). It is estimated that the number of microbes in the colon at least 
match the total number of host cells in a human [20]. The microbiota create a 
complex ecosystem where several species compete with, depend on or influence 
each other. Importantly, the microbial community in the colon is highly diverse with at 
least ~ 1000 different species. Despite some redundancy in function between 
species, this means that the combined microbial ‘genome’ is more than 100-fold 
greater than the host’s. This has important implications to the host, as the microbiota 
contain unique genes that are absent in the host’s genome. Many of these genes 
encode enzymes that break down dietary components, such as complex 
carbohydrates, and make these absorbable and available to the host. In this way, the 
microbiota make an important contribution to the host’s extraction of nutrients and 
energy from the diet [21]. This can be seen in germ-free mice that are usually leaner 
then their microbiota containing counterparts [22]. In addition to helping in the 
digestion of food, bacteria also synthesize essential vitamins and are key in training 
the immune system. Furthermore, our normal, commensal microbiota protect us from 
pathogenic microbes, in part by simply competing them out of space and nutrients. 
Thus, the microbiota exert an important and largely beneficial role in our life. In their 
role in digesting food and generating vitamins, the microbiota could be considered 
almost an organ in our body. This notion is strengthened if one considers that 
structures in the gut, such as the caecum, evolved to house the microbiota. Yet, this 
would be a highly dynamic organ, not only changing dramatically in size depending 
on food intake and digestive status, but also in the species composition of microbes. 
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In fact, the microbial composition differs from person to person because the 
microbiota composition is strongly affected by nutrition, lifestyle and other factors 
[23,24]. 
Furthermore, the microbiome composition evolves during life time, from its 
acquisition during and after birth, maturing after weaning and changing even into old 
age [24]. However, the microbiota can turn into the enemy within us. Not only can we 
ingest harmful bacteria, such as Salmonella that invade and poison our body [25], 
our body can also overreact to the presence of the microbiota in the gut, for 
example, as a result of genetic predisposition. This can lead to inflammatory bowel 
diseases (IBD), such as Crohn’s disease and ulcerative colitis [26]. Furthermore, the 
microbiota have been identified as contributing factor in cancer processes, especially 
gastric and colon cancers. The role of Helicobacter pylori in gastric cancer is an 
illustration for this [27]. 
In summary, the microbiota are a dominant force in our lives and understanding how 
microbiota-host interactions are regulated is important.  
Crosstalk microbiota-host through microbial metabolites 
The crosstalk between microbiota and host occurs through a large variety of 
molecules, such as bacterial structural components and metabolites. Bacterial cell 
wall components or flagellar proteins are recognized by the host’s cells through 
specific receptors (so called pattern recognition receptors, PRRs) in innate immune 
responses. Toll-like receptors are well studied PRRs. The microorganism-associated 
molecular patterns (MAMPs) include lipopolysaccharides, flagellin, and 
peptidoglycans. These initiate signalling cascades, e.g., leading to an anti-bacterial 
response through generation of cytokines, chemokines and/ or anti-bacterial 
peptides (reviewed in [28,29]). Another important mechanism by which the 
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microbiota interact with the host is through the generation of bioactive molecules that 
are taken up in the host’s cells and affect cellular functions, especially gene 
regulation [29]. There are several key metabolites that have been studied in this 
context, which include short chain fatty acids (SCFA), polyamines, vitamins and aryl 
hydrocarbon receptor (AHR) ligands. Figure 2 summarises some of these bacterially 
derived molecules and their impact on the host. 
The AHR is a nuclear receptor type of transcription factor that is activated by binding 
to diverse ligands, including xenobiotics, plant or bacterial metabolites or bacterial 
pigments [30–32]. AHR function has been shown to be required for intestinal 
immunity in mice by maintaining intestinal intraepithelial lymphocytes [30].  
Bacteria synthesize several vitamins such as B12 (cobalamin), riboflavins and folate 
[33]. As folate is required for DNA and histone methylation, the commensal bacteria 
have a potentially broad impact on epigenetic mechanisms [34,35].  
Polyamines (PA) such as spermine, spermidine and putrescine are essential for life 
in eukaryotes and prokaryotes, being involved in many processes, such as gene 
expression, chromatin structure regulation, stress response, differentiation and 
proliferation (for review: [36]). Normally, PA are derived from the diet and absorbed 
by the small intestine, but can also be generated by the microbiota in considerable 
amounts in the colon, where they are thought to support epithelium health [36]. How 
microbial PA affect the host’s chromatin is poorly understood.  
SCFA constitute a major class of bacterial metabolites. They are generated by the 
microbiota through the fermentation of complex carbohydrates as a metabolic waste 
product in the colon (and in many animals in the caecum) to large amounts and have 
a profound impact on the host’s physiology (reviewed in: [37]). The major microbial 
derived SCFA are acetate, propionate and butyrate. Estimates of SCFA 
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concentration vary between studies and different diets, but Rombeau and associates 
approximated SCFA concentrations in the content of the human colon to be 75 mM 
for acetate, 30 mM for propionate and 20 mM for butyrate [38]. These SCFA are 
generated by several bacterial species and there is cross-feeding between bacterial 
species, e.g. acetate and lactate producing Bifidobacterium species have been 
shown to feed the butyrate producing Faecalibacterium prausnitzii [39].  
While acetate and propionate are released into the blood stream through the portal 
vein, butyrate is mostly absorbed and metabolized by the colon epithelium, which 
constitutes the preferred energy source in this tissue [21]. In fact, the absence of 
microbiota in germ-free mice and, therefore, the lack of SCFA causes a complete 
remodelling of metabolism in the colon epithelium with a dramatic upregulation of 
autophagy to compensate for the loss of microbial SCFA [21]. Antibiotic treatment to 
deplete microbiome confirms the importance of the microbiota in energy generation 
and metabolism [40]. The oxidation of butyrate in the epithelium affects O2 levels, 
causing activation of the oxygen sensor HIF1, which in turn affects the response to 
pathogens [41,42]. Butyrate inhibits cellular proliferation  of intestinal stem/progenitor 
cells at physiologic concentrations and it has been suggested that the epithelial 
cellular anatomy reflects this influence, protecting the stem and proliferating cells 
from the effects of butyrate by sequestering them in crypts [43]. Thus, butyrate has 
different impacts on cells dependent on their location along the crypt axis - with stem 
cell niche being relatively depleted of butyrate while villus cells use butyrate as a 
principal carbon source [43]. 
Butyrate and propionate are effective HDAC inhibitors at the concentrations that are 
generated in the colon and this constitutes an important mechanism by which these 
SCFA affect physiology. SCFA also activate G-coupled-receptors (GPCRs, also 
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called free fatty acid receptors, FFARs). GPR43 and 41 have been studied in this 
respect. In both capacities, as HDAC inhibitors and activators of GCPRs, the 
bacterial derived SCFA suppress inflammatory responses (reviewed in [37]). SCFA 
might also promote histone modifications by metabolic conversion to the acetyl-CoA 
and other SCFA-CoA precursors to be transferred to histones by HATS such as 
p300/CBP (see below, [44,45]). 
 
Histone modification in the microbiota-host crosstalk 
It has been known for decades that there is a link between fiber content of diet, 
production of SCFA by the microbiota and histone acetylation in the gut [46] . More 
recently, a study examined the effect of the microbiota and diet on histone 
modifications using mass spectrometry analysis [47]. The researchers employed 
conventionally raised, germ-free and microbiota-re-colonized (“conventionalized”) 
mice to address the role of the microbiota [47]. Since conventionally raised animals 
exhibit developmental differences versus their germ-free controls (reviewed in: [48]), 
the use of the conventionalized mice allowed for studying of effects related to the 
presence or absence of the microbiota directly. This study is important as it showed 
that the gut microbiota effected histone acetylation and methylation not only in the 
colon, but also in the liver and white adipose tissue and that generation of SCFA by 
the microbiota is a dominant driver of this. The researchers found that the presence 
of microbiota robustly promoted histone acetylation of H3 and H4 at multiple lysine 
residues in the various tissues, whilst changes in H3 methylation were subtle, but still 
significant [47]. Some histone PTMs appeared to be similarly regulated across all 
tissues surveyed, whilst other changes were tissue specific. Interestingly, feeding 
mice a diet high in fat and sucrose and low in fermentable complex carbohydrates 
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(HF/HS-diet, “western-style diet”) suppressed microbiota-driven SCFA production 
and chromatin effects observed in a fiber-rich diet. HF/HS-fed conventionally raised 
mice displayed higher hepatic total cholesterol and triglycerides versus diet-matched 
germ-free controls and chow-fed mice, showing that HF/HS feeding impacted the 
host’s metabolic state in a microbiota-dependent manner. The presence of 
microbiota and the diets manifested themselves in gene expression in the liver and 
many affected genes related to metabolism. 
Gut microbiota altered expression of genes linked to metabolites that are required for 
histone PTMs. For example, expression of ATP citrate lyase (Acly) an enzyme 
essential for glucose-driven, but not acetate-driven, histone acetylation in 
mammalian cells [49], was decreased in conventionally raised versus germ-free 
mice, under both chow and HF/HS feeding [47]. This suggested that the presence of 
bacterial SCFA or lipids from HF/HS feeding, may suppress glucose-driven histone 
modification. The authors did not examine how changes of histone modifications, 
e.g., over promoters, are linked to changes in gene expression, e.g., by ChIP-seq. 
Yet, overall, this study highlights the intimate link between diet, the microbiota and 
genome-regulation in the whole organism. 
 
Alternative histone acylations in the microbiota-host crosstalk 
Progress in the analysis of histone PTMs by mass spectrometry has allowed the 
identification of a range new modifications, many of which can be summarised as 
alternative acylations. These include histone crotonylation, butyrylation, 
hydroxybutyrylation and propionylation (reviewed in: [50–52], see Table 2 for a 
summary). These modifications are also linked to metabolic pathways. For example, 
histone crotonylation is promoted by addition of crotonic acid to cell culture media, as 
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crotonic acid is converted to crotonyl-CoA by the enzyme ASCC2 [53]. Histone 
crotonylation changes the functionality of nucleosomes compared to histone 
acetylation as it creates specific binding platforms for YEATS domain containing 
chromatin remodelling factors. Although both modifications are associated with 
active chromatin, crotonylation promoted gene expression to a greater extent than 
acetylation in a cell-free assay [54–56].  
We used mass spectrometry to canvas PTMs, including crotonylation, in histones 
isolated from the intestinal epithelium [57]. We found that histone crotonylation is a 
relatively abundant modification in the intestinal epithelium (and the brain) with 
H3K18cr identified as the most prevalent crotonylation. When we acutely depleted 
microbiota in mice with a 3-day course of a cocktail of antibiotics, this not only 
reduced luminal SCFA, but significantly affected global histone crotonylation levels in 
the gut. We could show that butyrate acted as a histone decrotonylase inhibitor and 
found, consistent with several other studies published around that time [58,59], that 
class I HDACs are potent histone decrotonylases [57]. Therefore, our study 
emphasizes inhibition of HDACs through SCFA, especially butyrate, as an important 
mechanism for the microbiota-host crosstalk. Similar to what has been shown in 
other cell types, we found H3K18cr ‘peaks’ over promoter regions of many genes 
and its level seems to correlate with gene expression [53,57]. Interestingly, many of 
the genes with higher levels of crotonylation over their promoters have been linked to 
cancer pathways. More recently, we found that promoter chromatin crotonylation 
reflects gene expression changes dependent on microbiota (Fellows et al., in 
revision). Thus, it appears that promoter crotonylation is an important mechanism for 
the microbiota-host crosstalk in the gut. Our current model how bacterial derived 
SCFA affect histone crotonylation is shown in Figure 3. 
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HDACs in microbe-host interactions 
The previous sections have already highlighted the importance of HDACs in the 
microbiota-host crosstalk, mainly because the microbial-derived butyric and 
propionic acids are HDAC inhibitors. Thus, it is not surprising that HDACs were 
found to have a critical role in the microbiota-host crosstalk. This is well illustrated 
with HDAC3 in a study from the Artis lab [60]. Intestinal epithelium specific deletion 
of HDAC3 (HDAC3∆IEC) led to gene expression and corresponding H3K9ac level 
changes at affected genes and a progressive loss of Paneth cells, with evidence of 
Paneth cell death [60]. Paneth cells are found at the base of the small intestinal 
crypt, where they play a role in regulating microbiota-host interaction by secreting 
anti-bacterial peptides (See Fig. 1, [61]). Thus, consistent with the loss of Paneth 
cells, the HDAC3∆IEC mice exhibited increased translocation of bacteria through the 
epithelium and increased intestinal inflammation, as well as increased susceptibility 
to oral Listeria monocytogenes infection. Remarkably, Paneth cell viability was not 
affected in HDAC3∆IEC mice raised under germ-free conditions and alterations in the 
majority of HDAC3-dependent transcriptional pathways, including those involved in 
anti-microbial defence, were not seen. Thus, it appears that HDAC3 is required to 
respond to bacterial cues and translates this to a gene expression program that 
protects intestinal integrity. A follow-up study from the Alenghat lab demonstrated 
that HDAC3 mediates communication between intestinal epithelial cells and resident 
lymphocytes, thereby promoting resistance against infection by pathogenic microbes 
[62]. Whether these actions of HDAC3 occur through deacetylation of histones or 
other factors, or an enzymatic independent role of HDAC3 remains to be discovered.  
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Furthermore, it will be exciting to find out what are the bacterial cues involved in 
these pathways. 
Sirt1 belongs to the class III group of NAD+ dependent deacetylases, also called 
sirtuins. Several sirtuins deacetylate histones, but they also have other targets. 
Epithelial deletion of Sirt1 led to age-dependent enhanced inflammation in one study 
[63], while another study reported protection against colitis and enhanced anti-
bacterial defence in the intestine [64]. Both studies reported changes in the 
microbiota upon the Sirt1 deletion. If chromatin deacetylation is involved in these 
observations remains to be elucidated, deacetylation of transcription factor SPDEF 
was implicated in the observed activity of Sirt1 in the intestine [64]. 
Another class III deacetylase/ sirtuin is Sirt2. Studies of this enzyme in cultured 
human cell lines (epithelial cervical adenocarcinoma cell line Hela and colorectal 
adenocarcinoma cell line Caco2) and mouse spleen tissue showed that this enzyme 
has a critical role in the pathogenic infection of cells by Listeria monocytogenes [65]. 
Sirt2 is normally predominantly cytosolic, but upon infection by Listeria 
monocytogenes, it translocates to the nucleus to tightly bind to chromatin and to 
deacetylate H3K18ac. This, in turn, leads to repression of genes normally involved in 
limiting infection [65,66]. These findings highlight (1) H3K18 as a potentially critical 
residue in host-pathogen interaction, (2) show that a histone modifier is essential for 
infection by a pathogen and (3) illustrate how bacteria can subvert the host’s 
biochemistry for their own purposes. Overall, the studies described above highlight 
the importance of histone deacetylation in host-microbe crosstalk. Future studies will 
need to address to what extent histone deacylation processes, such as 
decrotonylation, are important in this crosstalk, as many HDACs can remove other 
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acyl-groups from histones, such as HDAC1-3 acting as decrotonylases and SIRT3 
as a dehydroxybutyrylase (see Table 2, [57–59,67]).  
 
The microbiota affect histone modifications over regulatory elements in 
conjunction with diet 
Several histone modifications are linked to regulatory elements such as promoters 
and enhancers. For example, H3K27ac in combination with H3K4me1 is often found 
over active enhancers, while H3K4me1 without H3K27ac marks poised enhancers. 
Therefore, such histone modification combinations are used to identify candidate 
enhancer elements [68]. A study from the Wade lab examined how the microbiota in 
combination with diet affected H3K27ac and H3K4me1 genome wide using ChIP-seq 
in colon epithelial cells in the mouse model [69]. Consistent with previous work, they 
found that an obesogenic diet markedly altered the gut microbiota. This, in turn, 
caused a reduction of microbial derived butyrate and changes in mouse metabolic 
physiology. Their findings show that the gut microbiota in combination with an 
obesogenic diet (high fat diet, HFD) changes the enhancer landscape with respect to 
these modifications and also affected binding of a critical transcription factor in the 
host-microbiota crosstalk, HFN4alpha, along with concomitant changes in gene 
expression. Furthermore, they found that many of these changes were similar to 
those seen in the colon cancer process. Remarkably, transplantation of the bacteria 
from the HFD-fed, but not from the control diet-fed mice, into germ-free mice led to 
recapitulation of the HFD-associated epigenetic changes. This work demonstrates 
how an obesogenic diet, in combination with the microbiota, may impact disease 
risk, potentially predisposing to cancer by activating pathways similar to those found 
in cancer cells. The authors speculate that the HFD microbiota is involved in 
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generating metabolites from the HFD that lead to an epigenetic reprogramming of 
the enhancer landscape, illustrating the complexity in the microbiota-diet-host 
interactions [69].  
 
Epigenetics and IBD: histone H3K4me3 changes link IBD to microbiota-host 
interactions 
In general, the causes of IBD are complex, involving triggers from the environment 
and genetic susceptibility of the host [26]. Aberrant microbiota-host interactions are 
prime candidates driving IBD and it is important to understand to what extent 
epigenetic pathways underlie these defective responses. Alterations in DNA 
methylation have already been linked to IBD [70–74], but what about other 
epigenetic features? A recent study mapped genes that showed changes in the 
histone modification H3K4me3 in intestinal epithelial cells from terminal ilea of newly 
diagnosed pediatric Crohn’s disease (CD) patients and compared these findings with 
changes in gene expression [75]. Remarkably, the changes in H3K4me3 seemed to 
identify the CD patients more robustly than the changes in gene expression. The 
researchers compared these changes with those seen in H3K4me3 in ileal epithelial 
cells between germ-free mice and conventionally housed mice. These global 
analyses showed that the presence of microbiota in the gut resulted in many 
changes in H3K4me3 in IECs. This demonstrated furthermore that a significant 
proportion of the loci identified in the patients exhibited changes in the mice 
dependent on the presence of the microbiota, identifying an “epigenetic profile of IBD 
that can be primed by commensal microbes” [75]. The patient sample number in this 
work was relatively small, and thus, it would be very interesting to see this type of 
study expanded with more patients, maybe with different forms of IBD. Yet, this 
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study sheds new light onto pathways by which microbiota might predispose to 
intestinal inflammation and illustrates how epigenetic analyses can complement 
other approaches for identification of epithelial abnormalities. 
 
Demethylase KDM5 and the microbiota in the gut-brain axis 
There is tantalising evidence that suggests a role of the gut microbiota in intellectual 
disability (ID) and autism spectrum disorder diseases (ASD). Genome-wide 
association and family studies have implicated several chromatin remodelling factors 
and histone modifiers in these diseases, including members of the KDM5 family of 
demethylases that remove histone H3K4 methyl groups. A group of researchers took 
advantage of the fact that that Drosophila has only one KDM5 paralog (human has 
four KDM5 paralogues) and that this organism has a relatively simple microbiota, to 
examine the role of KDM5 in intellectual deficiency and autism spectrum disorder 
behaviour models in the fly [76]. They found that reduced levels of KDM5 in a fly 
kdm5 mutant caused global increase in H3K4me3 in the gut concomitant with 
intestinal barrier disruption, making the gut permeable to microbes. This was 
accompanied by a change in the gut microbiota, including reduction of Lactobacillus 
plantarum L168, and impaired fly social behaviour. These changes were not 
observed in flies reared germ-free or after antibiotics treatment. Probiotic treatment 
of mutant flies with Lactobacillus plantarum L168 restored intestinal barrier function 
and improved social behaviour towards normal. Together, the findings indicate that 
ablation of KDM5 causes a change in behaviour, at least in part by altering the gut 
microbiota. Furthermore, the reported activities of KDM5 depended on its 
demethylase activity and the researchers implicated miss-regulation of innate 
immunity genes to an aberrant increase in H3K4me3 over their promoters. While this 
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study does not rule out that a non-histone target is critical in the described functions 
of KDM5, it is likely that chromatin regulation plays an important role in the process. 
It is as yet not clear exactly how the miss-regulation of the microbiota on KDM5 
mutation affects social behaviour. However, the researchers implicate an increase of 
the neurotransmitter serotonin, which may be microbiota dependent. Interestingly, 
another study identified histone serotonylation in combination with methylation 
(H3K4me3Q5ser) as a new histone PTM linked to active genes [77]. This new 
modification was found to be most abundant in the brain and gut. Whether there is a 
link between the microbiota and histone serotonylation remains to be investigated. In 
summary, the study on KDM5-microbiota interaction is an exciting illustration of how 
chromatin dynamics links the microbiota to physiology of tissues far from the gut, 
opening the question if manipulation of the gut microbiota could ameliorate ID and 
ASD in human. 
 
ATP-dependent chromatin remodelling factor CHD1 and host-microbiome 
interactions in Drosophila 
Drosophila with its relatively simple microbiome also provided insights into the role in 
host-microbiome interaction of a member of another important class of chromatin 
factors, the ATP-dependent nucleosome remodelling factors: CHD1, which is 
required for the replication independent incorporation of histone H3 variant H3.3 into 
chromatin [78]. Following the observation that deletion of this factor led to 
misregulation of genes involved in immune responses, stress responses and 
detoxification in larvae, the group of Alexandra Lusser found that loss of CHD1 led to 
an increased expression of anti-microbial peptides (AMP) in the gut. However, it also 
rendered flies susceptible to infection by the bacterium Pseudomonas aeruginosa 
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upon ingestion of the bacteria [79]. They found that bacterial load was significantly 
elevated in the Chd1 mutant flies in the gut and in the fly body outside the gut after 
oral infection. This suggested that the gut epithelium was much more permissible to 
the passage of P. aeruginosa and possibly other bacteria into the hemolymph, 
causing the flies to die. These findings suggest that a misbalance of expressed AMP 
and other immune factors may have led to dysbiosis and, thus, susceptibility to the 
P. aeruginosa infection. To substantiate this further, the group performed 
microbiome analysis using 16S rRNA sequencing [80]. This showed a loss of 
species diversity in the mutant flies. For example, on the family level, the bacterial 
community in the wildtype flies’ guts of Pseudomonadaceae, Enterobacteriaceae, 
Comamonadaceae and Staphylococcaceae together comprised ~19% of the fly 
microbiota, but these families were nearly absent in the Chd1-mutant flies. 
Complementary PCR-based assays showed the loss of Chd1 correlated with an 
accumulation of Acetobacter and a decrease of Lactobacillus species. These effects 
were age dependent, being more pronounced in younger flies. Importantly, the 
authors showed that Chd1-/- flies were unable to sustain Lactobacillus plantarum 
titres after dietary supplementation. Future research needs to determine to what 
extent gene regulation relevant to microbe-host interaction is the direct result of 
chromatin remodelling by CHD1 over the genes as opposed to some indirect effects. 
It will also be very exciting to find out if the role of CHD1 in host-microbe interaction 
is conserved in mammals.  
 
Outlook 
The microbiota affect gene regulation of the intestinal epithelium in various ways, of 
which the generation of SCFA is a dominant pathway. Inhibition of HDACs by SCFA 
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is an important mechanism. As SCFA also are an important energy source in the gut, 
future studies need to unravel to what extent SCFA affect chromatin by providing 
metabolic precursors in the cell, e.g., butyryl-CoA, for mediating alternative histone 
acylations.  
Microbiota-host interactions are fascinating and important to study. Yet, this field 
poses many challenges [81]. While we presented several examples in this review, 
where deletion of chromatin factors affected host-microbiome interactions, the extent 
to which the microbiome is affected by genetic variation in the general population is 
an area of debate and intense research [23,82]. A huge problem in studying 
microbiota-host interactions is the fact that the microbiota is highly dynamic and 
diverse. Therefore, mice in various facilities, even SOPF (specific or pathogen free), 
differ markedly in their microbiota, resulting, e.g., in different outcome in 
experimental colitis outcomes (see for example, [83]). Furthermore, mice in clean, 
SOPF facilities have a reduced microbiota, with consequences to their immune 
system and physiology [84–86]. Therefore, future studies should consider the normal 
rich  ‘healthy’ microbiota of wild mice. These problems are even more challenging 
considering the human microbiome where greater diversity in genetic background, 
lifestyle and other factors further complicate studies of the interaction between host 
and microbiota. 
While we focused here on the gut microbiota, mucosal surfaces in other tissues are 
covered with their specific microbiota. For example, the uterus has a microbiota that 
affects pregnancy outcomes [87]. The inter-kingdom crosstalk is important in all 
these compartments and regulation through chromatin dynamics is likely going to be 
an important facet here, too. We are only at the start of unravelling the mechanism of 
microbiota-host interactions, many of which have been ‘hard-wired’ into our genome 
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through billion years of co-evolution. In the future, more aspects of chromatin 
dynamics are likely to be revealed as being essential in this process. 
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Table 1: Glossary  
Term Definition and explanation 
Acylation A group of post-translational modifications made by covalently 
adding functional groups to amino acid residues on proteins 
through acyl linkages. One main type is fatty acylation, the 
addition of fatty acyl chains to proteins. Acylations include 
formylation, acetylation, propionylation, crotonylation, 
butyrylation, hydroxybutyrylation, malonylation, glycosylation, 
succinylation, benzoylation and palmitoylation. 
AhR  Aryl hydrocarbon receptor is a ligand activated transcription 
factor which regulates a variety of cellular processes. Ligand 
activation causes dissociation from its chaperone HSP90 and 
binding to aryl hydrocarbon receptor nuclear translocator 
(ARNT). AhR is an important regulator of immune responses.  
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Anti-microbial 
peptides (AMPs) 
A diverse group of peptides expressed as part of the innate 
immune host defence (therefore, also called host defence 
peptides, HDPs). The peptides are usually small (12-50 amino 
acids) and function, for example, by destabilizing the bacterial 
cell membrane. A group of these peptides are called defensins 
which are cysteine-rich cationic peptides. Some defensins are 
expressed by Paneth cells at the base of the crypts of the small 
intestine. 
Bromodomain The bromodomain is a protein motif that is conserved in 
eukaryotes and found in over 100 proteins. It preferentially 
binds acetylated lysine residues such as those found on 
histones. 
Commensal 
bacteria 
These bacteria are part of the microbiota, e.g., in the gut. They 
do not hurt the host, but also do not provide significant 
benefits. 
Conventionalized 
mouse 
A mouse that was initially germ-free (see below) but has been 
re-colonized with normal microbiota. 
Epigenetics The study of heritable phenotypic changes in gene expression 
without changing the underlying DNA sequence. Deriving from 
the Greek ‘epi’ meaning on or above. This term is often used to 
describe many DNA and chromatin associated modifications.  
Gastrointestinal 
tract 
An organ system which takes in, digests and absorbs nutrients 
along with removal of waste products. It comprises the mouth, 
esophagus, stomach, small intestine (duodenum, ileum and 
jejunum), caecum (and attached appendix), colon, rectum and 
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anal canal. 
Germ-free mouse Germ-free animals have no microorganisms living in or on 
them. Generation and maintenance of germ-free mice is a 
challenging task. Germ-free mice are bred in isolators that 
block exposure to microorganisms, keeping them free of 
detectable bacteria, viruses, and eukaryotic microbes. Re-
colonising these mice with defined microorganisms generates 
gnotobiotic mice. An alternative to using germ-free mice is 
treating mice with a cocktail of antibiotics to get rid of a majority 
of bacteria [22]. 
GPCRs G protein coupled receptors are a large family of membrane 
proteins that bind a specific molecule on the extracellular side 
and couple to a signalling response on the intracellular side. 
Ligand binding triggers a conformational change that activates 
the alpha subunit of the G protein which releases the gamma 
and beta subunits to generate further signalling reactions in the 
cell to elicit a response. 
HDAC Histone deacetylase. HDACs should really be called lysine 
deacetylases (KDACs) as they also deacetylate proteins other 
than histones. Based on sequence homology, 18 human 
HDACs are grouped into four classes. Class I enzymes are 
comprised of HDAC1, 2, 3, and 8. Class II enzymes are 
HDAC4, 5, 6, 7, 9 and 10. Class III enzymes consist of seven 
sirtuins, which are NAD-dependent protein deacetylases and/or 
ADP ribosylases. Class IV contains only HDAC11, which 
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shares sequences similarity to both class I and II proteins. 
Several inhibitors against HDACs have been developed with 
promise in cancer therapy [88]. 
Hemolymph The equivalent of blood in vertebrates, the hemolymph is a 
fluid that circulates around the interior of arthropod bodies as 
part of the open circulatory system to exchange materials with 
tissues. Arthropods include Drosophila melanogaster, used 
frequently as a model organism in biological research. 
Histone code The histone code hypothesis was formulated to express the 
idea that histone modifications, including combinations of these 
modifications, regulate DNA templated processes, such as 
transcription [89]. Furthermore, histone modifications are 
thought to act, at least in part, by creating binding platforms for 
effector proteins, such as nucleosome remodelling factors. 
IECs Intestinal epithelial cells line the gut lumen and form the first 
line of defence after the barrier of mucus layer (see Figure 1). 
Stem cells in the crypt base generate Paneth cells, label 
retaining cells, transit amplifying cells, enterocytes, 
enteroendocrine cells, tuft cells and goblet cells required for 
maintaining the epithelial niche. IECs are supported by the 
lamina propria. 
IELs Intestinal epithelial lymphocytes are T lymphocytes derived 
from naïve T cells in the thymus and are present in the 
epithelial and lamina propria layers of the intestine. Upon 
detection of antigens they release cytokines to kill infected 
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cells. 
Inflammatory 
bowel diseases 
Chronic disorders of the digestive tract associated with 
prolonged inflammation. Two main types are ulcerative colitis, 
which occurs in the colon, and Crohn’s disease which can 
occur anywhere along the gastrointestinal tract.  
MAMPs Microbial (or pathogen) associated molecular patterns are 
motifs of microbial specific structures that elicit a host 
response. They include flagellin, lipopolysaccharide, xylanase 
elongation factor Tu, peptidoglycan and viral single stranded 
RNA.  
Microbial dysbiosis An imbalance in the microbiota associated with 
overrepresentation of certain bacterial species. Caused by 
antibiotic use, poor diet or chronic stress. There is insufficient 
evidence as to whether microbial dysbiosis is a direct cause of 
inflammatory diseases or a result of it. As the microbial species 
are highly variable between individuals, determining when the 
microbiota is in dysbiosis can be difficult. A more narrow 
definition describes microbial imbalance which causes disease, 
in line with Koch’s postulates (criteria for establishing a causal 
relationship between a microbe and disease).     
Microbiome This term is sometimes used synonymously to microbiota. 
However, the narrower definition is ‘the collective genomes of 
the microbiota in or on an organism’. The microbial genome 
has typically 100 times more genes than the host genome. 
Major phyla of the human bacterial gut microbiome are: 
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Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria. 
Microbiota The community of microorganisms (bacteria, archaea, fungi 
such as yeasts, protozoa, viruses and phages) found in and on 
a multicellular organism. These microorganisms may be 
symbionts, commensal or pathogenic. The word microbiota is a 
plural term (singular would be ‘microbiotum’) 
similar to the term ‘people’.  
Nucleosome The basic unit of DNA packaging consisting of an octamer of 
H2A, H2B, H3 and H4 histones which coil approximately 146 
base pairs of DNA.  
Obesogenic diet A high fat diet given to mice to induce obesity. 
PRRs Pattern recognition receptors are a key element of the innate 
immune system. Receptors identify bacterial signals to enable 
responses to pathogenic bacteria. PRRs include Toll-like and 
nucleotide binding oligomerisation domain (NOD)-like, C type 
lectin and RIG-1 like receptors. 
PTM Post-translational modification. Chemical modification of amino 
acid residues after their assembly into a protein during 
translation by the ribosome using an mRNA template. This can 
alter the chemical properties of the protein or change 
interactions with other proteins. PTMs include acetylation, 
phosphorylation, hydroxylation, glycosylation, lipidation, 
ubiquitination,  or deamidation.  
SCFA Short chain fatty acid(s). A carboxylic acid less than six 
carbons in length. The predominant SCFA in the intestine are 
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acetate (C2), propionate (C3) and butyrate (C4). Other SCFA 
include formate (C1), crotonate (C4), isobutyrate (C4), valerate 
(C5) and isovalerate (C5).   
SOPF Specific or pathogen free. Laboratory organisms free from 
certain infectious agents that are capable of pathogenicity or 
may interfere with an experiment. 
Westernised diet A high fat, high salt diet given to laboratory mice to replicate a 
‘typical’ diet consumed in developed countries. 
Xenobiotics A chemical compound not normally produced or consumed by 
an organism. These foreign compounds can be drugs, 
carcinogens or pesticides. 
YEATS domain Named after the domain containing Yaf9, ENL, AF9, Taf14 and 
Sas5 proteins, the YEATS domain is a protein motif that 
preferentially binds crotonylated lysine residues. This domain 
has been linked to chromatin structure and gene expression. 
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Figure 1. The structure of the small intestine and colon epithelium 
The intestine has a large surface area to enable efficient absorption of nutrients from the 
diet. This is comprised of pocket-like crypts, containing stem cells which generate all of the 
necessary cell types for the intestinal epithelium. Cells develop as they move up the crypt 
walls before being lost by anoikis (apoptosis induced by loss of cell contact) into the gut 
lumen. In the small intestine, cells are lost at the top of villi which are finger like projections 
that further increase surface area. There are many cell types in the intestine, the absorptive 
enterocytes and the mucus secreting goblet cells are the most abundant. Transit amplifying 
cells are proliferative and lineage committed to become enterocytes. Enteroendocrine cells 
secrete hormones, tuft cells secrete prostanoids and opioids, and Paneth cells secrete 
antimicrobial peptides and support the stem cells. Label retaining cells are quiescent Paneth 
cell precursors [90]. The small intestine contains a single diffuse layer of mucus which is not 
attached to the epithelium and contains some bacteria. The colon contains inner and outer 
mucus layers. The inner mucus layer is compact and attached to the epithelium and is 
normally free from bacteria. The outer mucus layer is diffuse with an undefined border and 
  MOLMET-D-19-00091-rev 
 28 
provides a habitat for intestinal bacteria. The colon microbiota is larger and more diverse 
than that of the small intestine [91]. The lamina propria is a thin layer of connective tissue 
which supports the epithelial cell niche. Intestinal associated immune cells, lymphatic 
vessels and capillaries are not shown. The muscularis mucosae, a thin layer of muscle, 
separates the lamina propria from the underlying submucosa (not shown). The epithelium, 
lamina propria and muscularis mucosa together make the mucosal layer [92] 
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Figure 2. Microbial metabolites influence host function 
A non-exhaustive list of microbial generated molecules and their effects on cellular and 
organismal function. Some of the bacteria species that generate the specified metabolites 
are listed on the arrows. References for (A) [34,35,93–98] (B) [36,99] (C) [100,101] (D) 
[30,102] (E) [103–108] (F) [109–114] (G) [115,116] (H) [99,117–121] (I) [122–125] (J) 
[122,123,126–128] (K) [37,38,40–42,122–124,129,129–133] (L) [28,29,134] 
 
Table 2: Histone acylations and their ‘writers’, ‘readers’ and ‘erasers’. 
Modification Structure Writer Reader Eraser 
Acetylation 
 
p300 (CBP, 
p300), MYST 
(Tip60, MOF, 
MOZ, HBO1), 
GCN5 (GCN5, 
PCAF) (a) 
Bromodomain 
(BRD2, BRD9, 
TAF1, CECR2), 
PHD (MOZ, 
DPF2) and 
YEATS (AF9, 
YEATS2) (b) 
Zn²⁺ dependent 
(HDAC1-11), 
NAD⁺ 
dependent 
(SIRT1-7) (c) 
Propionylation 
 
p300/CBP, 
PCAF, GCN5, 
MOF, HBO1, 
MOZ (d) 
Most BRDs 
(CECR2, BRD2-
4,7,9, TAF1), 
MOZ, DPF2, 
AF9 YEATS2 (e) 
SIRT1/2/3 
(f) 
Butyrylation 
 
p300/CBP, 
PCAF, GCN5 
(g) 
TAF1(2), BRD7, 
BRD9, CECR2, 
MOZ, DPF2, 
AF9 YEATS2 (h) 
SIRT1/2/3 (i) 
Crotonylation 
 
p300/CBP,  
MOF (j) 
TAF1(2), AF9, 
YEATS2, MOZ, 
DPF2 (k) 
HDAC1-3,  
SIRT1/2/3 (l) 
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β-
Hydroxybutyrylation 
 
p300/CBP (m) MOZ, DPF2 (n)    HDAC1-3,  
SIRT3 (o) 
Table 2. Histone acylations and their modifying enzymes 
Histone acylations are set down by ‘writers’, acyl-transferases, bound by ‘readers’ for downstream 
events and removed by ‘erasers’, de-acylases. References: (a) [135] (b) [136–138] (c) [139] (d) 
[51,140–144] (e) [145,146] (f) [147] (g) [51,140,141] (h) [50,55,56,145,146] (i) [147] (j) [148,149] (k)  
[50,54–56,58,145,146,150] (l) [57–59,151,152] (m) [144] (n) [146] (o) [52,56,67]. 
 
 
Figure 3. Current model of how microbial derived SCFA affect histone acetylation and 
crotonylation 
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The intestinal microbiota digests fibre present in dietary components, such as apples and 
brown bread, into SCFA. Butyrate is the main SCFA taken up by intestinal epithelial cells. 
Butyrate inhibits class I HDACs to reduce the removal of acetylation and crotonylation from 
the histone.  It might also promote histone crotonylation and acetylation by metabolic 
conversion to the acetyl-CoA and crotonyl-CoA precursors to be transferred to histones by 
p300/CBP. 
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• Chromatin dynamics of the host epithelium involving histone modifications 
play an important role in host-microbiota crosstalk  
 
• Microbiota-derived short chain fatty acids (SCFA) are a dominant determinant 
in microbiome-host interaction and the inhibition of histone deacetylases 
(HDACs) by SCFA is a key mechanism in this process.  
 
• Alternative histone acylations, such as crotonylation, reveal a new layer of 
complexity in host-microbiota crosstalk.  
 
 
